Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-12-20

FDA Approved: ORENITRAM — Original Application (United Therapeutics Corporation)

View source ↗

Summary

The FDA approved ORENITRAM (treprostinil) under an Original NDA from United Therapeutics, providing an oral formulation for pulmonary arterial hypertension. Thi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Orenitram (treprostinil)

Snippet

ORIG AP for ORENITRAM (TREPROSTINIL)